“Vaping has become the No. 1 behavioral issue in high schools, and...
Category:
Health
Latest
Loneliness poses risks as deadly as smoking: US surgeon general
Loneliness increases the risk of premature death by nearly 30%,...
Star Health Insurance earns profit of Rs 102 cr in Q4
“Retail health insurance will remain our primary focus for the...
Personal accident and health insurance in Asia-Pacific to reach $240.1bn in 2023:GlobalData
Varma concludes: “Personal accident and health insurance insurance is expected to see major developments as short-term accident covers, critical illness, disease-specific products become more mainstream. Furthermore, technology savvy middle class emerging markets and aging population in mature markets will support the business growth over the next few years.”
AstraZeneca and Oxford’s stories clash on COVID-19 vaccine
The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose. This diverged from the original plan of two full doses, given to the majority of participants.
The half-dose pattern was found to be 90% effective, versus the 62% success rate of the two-full-dose main study, based on interim data
India should begin scaling up syringe stocks for Covid vaccination: Experts
According to Rajiv Nath, Managing Director of Hindustan Syringes & Medical Devices Ltd, the estimated demand in India would be around 900 million pieces of different kinds of syringes for just one shot of the vaccine, considering 60-70 per cent of the country gets vaccinated.
“The number would amplify to 1.8 billion if the vaccine India chooses needs two shots,” Nath told IANS.
Britain gets ready for roll-out of Pfizer’s COVID-19 vaccine this week
Some of the most famous figures in British life stepped forward to say that they would receive the vaccine to encourage the public to follow suit. That could include Queen Elizabeth II and her husband Prince Philip, who are likely to receive the vaccine within weeks, according to MailOnline reports on Sunday.
India’s Serum Institute seeks emergency use nod for AstraZeneca’s COVID-19 vaccine
The move comes close on the heels of Pfizer Inc applying for a similar authorization of its coronavirus vaccine in India on Saturday.
COVID-19 caseload in India rises to 96.44 lakh with 36,011 new cases
The number of people who have recuperated from the disease surged to 91,00,792 pushing the national recovery rate to 94.37 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.
There are 4,03,248 active coronavirus infections in the country which comprises 4.18 per cent of the total caseload, the data stated.
Pfizer seeks emergency approval for COVID-19 vaccine in India, media say
The U.S. company, whose vaccine was recently approved by the British government, has written to the Drugs Controller General of India (DCGI), CNN-News18 reported citing a government source.Officials at the DCGI and the health ministry did not respond to requests for comment. A government official, however, told Reuters that no application had been received as of Saturday night.
COVID-19 could push number of people living in extreme poverty to over 1 billion by 2030: UN
“Severe long-term effects of the COVID-19 pandemic could push an additional 207 million people into extreme poverty on top of the current pandemic trajectory, bringing the total to over 1 billion by 2030,” noted the study.
The ‘Baseline COVID’ scenario, based on current mortality rates and the most recent growth projections by the International Monetary Fund (IMF), would result in 44 million more people living in extreme poverty by 2030 compared to the development trajectory the world was on before the pandemic.
Almost all COVID-19 patients develop antibodies: WHO
“What we understand is 90 to 100 per cent of people who are infected with the virus do develop an antibody response, whether you have mild infection or asymptomatic infection all the way to severe infection. And we’re still learning how long that antibody response lasts, how strong it is, how it relates to immunity from another infection, and how long that lasts,” Van Kerkhove, an expert on epidemiology, said at a virtual press briefing.
Moscow rolls out Sputnik V COVID-19 vaccine to most exposed groups
Scientists have raised concerns about the speed at which Russia has worked, giving the regulatory go-ahead for its vaccines and launching mass vaccinations before full trials to test its safety and efficacy had been completed.